Annual Total Expenses
$6.22 M
-$542.79 K-8.03%
31 August 2024
Summary:
Lexaria Bioscience annual total expenses is currently $6.22 million, with the most recent change of -$542.79 thousand (-8.03%) on 31 August 2024. During the last 3 years, it has fallen by -$192.19 thousand (-3.00%). LEXX annual total expenses is now -11.60% below its all-time high of $7.03 million, reached on 31 August 2018.LEXX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$2.29 M
+$460.16 K+25.19%
31 August 2024
Summary:
Lexaria Bioscience quarterly total expenses is currently $2.29 million, with the most recent change of +$460.16 thousand (+25.19%) on 31 August 2024. Over the past year, it has increased by +$996.66 thousand (+77.24%). LEXX quarterly total expenses is now -35.79% below its all-time high of $3.56 million, reached on 31 May 2018.LEXX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.0% | +77.2% |
| 3 y3 years | -3.0% | +13.4% |
| 5 y5 years | +45.2% | +142.0% |
LEXX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.6% | at low | -9.2% | +181.3% |
| 5 y | 5 years | -9.6% | +45.2% | -17.4% | +181.3% |
| alltime | all time | -11.6% | >+9999.0% | -35.8% | +476.7% |
Lexaria Bioscience Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2024 | $6.22 M(-8.0%) | $2.29 M(+25.2%) |
| May 2024 | - | $1.83 M(+124.7%) |
| Feb 2024 | - | $813.00 K(-37.0%) |
| Nov 2023 | - | $1.29 M(+12.7%) |
| Aug 2023 | $6.76 M(-1.7%) | $1.14 M(-53.8%) |
| May 2023 | - | $2.48 M(+84.5%) |
| Feb 2023 | - | $1.34 M(-25.1%) |
| Nov 2022 | - | $1.79 M(+108.6%) |
| Aug 2022 | $6.87 M(+7.3%) | $859.70 K(-65.9%) |
| May 2022 | - | $2.52 M(+70.2%) |
| Feb 2022 | - | $1.48 M(-26.7%) |
| Nov 2021 | - | $2.02 M(+51.3%) |
| Aug 2021 | $6.41 M(+43.6%) | $1.33 M(-51.9%) |
| May 2021 | - | $2.77 M(+113.7%) |
| Feb 2021 | - | $1.30 M(+28.5%) |
| Nov 2020 | - | $1.01 M(+1.0%) |
| Aug 2020 | $4.46 M(+4.2%) | $999.10 K(-29.4%) |
| May 2020 | - | $1.41 M(+28.6%) |
| Feb 2020 | - | $1.10 M(+16.4%) |
| Nov 2019 | - | $944.90 K(-17.7%) |
| Aug 2019 | $4.28 M(-39.1%) | $1.15 M(-8.3%) |
| May 2019 | - | $1.25 M(+7.1%) |
| Feb 2019 | - | $1.17 M(+63.7%) |
| Nov 2018 | - | $714.00 K(-46.0%) |
| Aug 2018 | $7.03 M(+266.6%) | $1.32 M(-62.8%) |
| May 2018 | - | $3.56 M(+129.9%) |
| Feb 2018 | - | $1.55 M(+158.2%) |
| Nov 2017 | - | $599.80 K(-10.1%) |
| Aug 2017 | $1.92 M(+50.9%) | $667.30 K(+79.9%) |
| May 2017 | - | $371.00 K(-21.9%) |
| Feb 2017 | - | $475.10 K(+17.3%) |
| Nov 2016 | - | $404.90 K(+20.1%) |
| Aug 2016 | $1.27 M(-34.5%) | $337.20 K(+29.5%) |
| May 2016 | - | $260.30 K(-2.0%) |
| Feb 2016 | - | $265.70 K(-35.0%) |
| Nov 2015 | - | $408.50 K(-33.7%) |
| Aug 2015 | $1.94 M | $616.30 K(+21.4%) |
| May 2015 | - | $507.70 K(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $456.00 K(+25.6%) |
| Nov 2014 | - | $363.00 K(-45.1%) |
| Aug 2014 | $1.27 M(+236.0%) | - |
| July 2014 | - | $661.60 K(+11.0%) |
| Apr 2014 | - | $596.30 K(+144.3%) |
| Jan 2014 | - | $244.10 K(-149.6%) |
| Oct 2013 | $378.40 K(-72.2%) | -$492.40 K(-279.1%) |
| July 2013 | - | $274.90 K(+9.5%) |
| Apr 2013 | - | $251.10 K(-27.2%) |
| Jan 2013 | - | $344.70 K(-5.6%) |
| Oct 2012 | $1.36 M(-2.2%) | $365.10 K(-3.3%) |
| July 2012 | - | $377.60 K(+23.7%) |
| Apr 2012 | - | $305.20 K(-3.0%) |
| Jan 2012 | - | $314.70 K(+110.2%) |
| Oct 2011 | $1.39 M(+86.4%) | $149.70 K(-71.4%) |
| July 2011 | - | $523.10 K(+55.6%) |
| Apr 2011 | - | $336.20 K(+0.2%) |
| Jan 2011 | - | $335.40 K(+73.3%) |
| Oct 2010 | $747.60 K(-26.4%) | $193.50 K(+44.2%) |
| July 2010 | - | $134.20 K(+10.5%) |
| Apr 2010 | - | $121.50 K(-59.3%) |
| Jan 2010 | - | $298.30 K(+31.5%) |
| Oct 2009 | $1.02 M(-27.1%) | $226.80 K(-23.4%) |
| July 2009 | - | $296.00 K(+22.7%) |
| Apr 2009 | - | $241.30 K(-4.0%) |
| Jan 2009 | - | $251.40 K(-26.3%) |
| Oct 2008 | $1.39 M(+6.9%) | $341.20 K(+28.8%) |
| July 2008 | - | $265.00 K(-20.1%) |
| Apr 2008 | - | $331.70 K(-15.1%) |
| Jan 2008 | - | $390.90 K(-164.4%) |
| Oct 2007 | $1.30 M(+462.3%) | -$607.10 K(-149.4%) |
| July 2007 | - | $1.23 M(+199.8%) |
| Apr 2007 | - | $410.30 K(+49.1%) |
| Jan 2007 | - | $275.20 K(+115.0%) |
| Oct 2006 | $231.80 K(+560.4%) | $128.00 K(+144.3%) |
| July 2006 | - | $52.40 K(+75.8%) |
| Apr 2006 | - | $29.80 K(+3.1%) |
| Jan 2006 | - | $28.90 K |
| Oct 2005 | $35.10 K | - |
FAQ
- What is Lexaria Bioscience annual total expenses?
- What is the all time high annual total expenses for Lexaria Bioscience?
- What is Lexaria Bioscience annual total expenses year-on-year change?
- What is Lexaria Bioscience quarterly total expenses?
- What is the all time high quarterly total expenses for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly total expenses year-on-year change?
What is Lexaria Bioscience annual total expenses?
The current annual total expenses of LEXX is $6.22 M
What is the all time high annual total expenses for Lexaria Bioscience?
Lexaria Bioscience all-time high annual total expenses is $7.03 M
What is Lexaria Bioscience annual total expenses year-on-year change?
Over the past year, LEXX annual total expenses has changed by -$542.79 K (-8.03%)
What is Lexaria Bioscience quarterly total expenses?
The current quarterly total expenses of LEXX is $2.29 M
What is the all time high quarterly total expenses for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly total expenses is $3.56 M
What is Lexaria Bioscience quarterly total expenses year-on-year change?
Over the past year, LEXX quarterly total expenses has changed by +$996.66 K (+77.24%)